These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 12513801)

  • 101. Acquisition of CD80 by human T cells at early stages of activation: functional involvement of CD80 acquisition in T cell to T cell interaction.
    Tatari-Calderone Z; Semnani RT; Nutman TB; Schlom J; Sabzevari H
    J Immunol; 2002 Dec; 169(11):6162-9. PubMed ID: 12444120
    [TBL] [Abstract][Full Text] [Related]  

  • 102. CTLA-4-Fas ligand functions as a trans signal converter protein in bridging antigen-presenting cells and T cells.
    Huang JH; Tykocinski ML
    Int Immunol; 2001 Apr; 13(4):529-39. PubMed ID: 11282992
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Blocking costimulatory signals to induce transplantation tolerance and prevent autoimmune disease.
    Khoury S; Sayegh MH; Turka LA
    Int Rev Immunol; 1999; 18(3):185-99. PubMed ID: 10614723
    [TBL] [Abstract][Full Text] [Related]  

  • 104. A role for CTLA-4-mediated inhibitory signals in peripheral T cell tolerance?
    Allison JP; Chambers C; Hurwitz A; Sullivan T; Boitel B; Fournier S; Brunner M; Krummel M
    Novartis Found Symp; 1998; 215():92-8; discussion 98-102, 186-90. PubMed ID: 9760573
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Human alloantigen-specific anergic cells induced by a combination of CTLA4-Ig and CsA maintain anti-leukemia and anti-viral cytotoxic responses.
    Comoli P; Locatelli F; Moretta A; Montagna D; Calcaterra V; Cometa A; Basso S; Zecca M; Maccario R
    Bone Marrow Transplant; 2001 Jun; 27(12):1263-73. PubMed ID: 11548844
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Absence of B7.1-CD28/CTLA-4-mediated co-stimulation in human NK cells.
    Lang S; Vujanovic NL; Wollenberg B; Whiteside TL
    Eur J Immunol; 1998 Mar; 28(3):780-6. PubMed ID: 9541571
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Induction of hapten-specific tolerance of human CD8+ urushiol (poison ivy)-reactive T lymphocytes.
    Kalish RS; Wood JA
    J Invest Dermatol; 1997 Mar; 108(3):253-7. PubMed ID: 9036920
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Immunomodulation with CTLA4-Ig in islet transplantation.
    Benhamou PY
    Transplantation; 2002 Jan; 73(1 Suppl):S40-2. PubMed ID: 11810061
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation?
    Linsley PS
    J Exp Med; 1995 Aug; 182(2):289-92. PubMed ID: 7543133
    [No Abstract]   [Full Text] [Related]  

  • 110. CTLA-4 upregulation during aging.
    Leng Q; Bentwich Z; Borkow G
    Mech Ageing Dev; 2002 Jul; 123(10):1419-21. PubMed ID: 12297345
    [TBL] [Abstract][Full Text] [Related]  

  • 111. [Blocking Two Signals of Immuno-Activated T Cells from Antigen Presenting Cells Can Prevent Chronic GVHD of Murine].
    Wu YB; Guo KY; Wang GZ; Dai XP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):557-562. PubMed ID: 29665932
    [TBL] [Abstract][Full Text] [Related]  

  • 112. CTLA4 mediates antigen-specific apoptosis of human T cells.
    Gribben JG; Freeman GJ; Boussiotis VA; Rennert P; Jellis CL; Greenfield E; Barber M; Restivo VA; Ke X; Gray GS
    Proc Natl Acad Sci U S A; 1995 Jan; 92(3):811-5. PubMed ID: 7846057
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Lipopolysaccharide-dependent down-regulation of CD27 expression on T cells activated with superantigen.
    Kai K; Rikiishi H; Sugawara S; Takahashi M; Takada H; Kumagai K
    Immunology; 1999 Oct; 98(2):289-95. PubMed ID: 10540229
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Abatacept and Glomerular Diseases: The Open Road for the Second Signal as a New Target is Settled Down.
    Trimarchi H
    Recent Pat Endocr Metab Immune Drug Discov; 2015; 9(1):2-14. PubMed ID: 25733062
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Cytokines and cancer immunotherapy.
    Wolf SF; Lee K; Swiniarski H; O'Toole M; Sturmhoefel K
    Immunol Invest; 2000 May; 29(2):143-6. PubMed ID: 10854183
    [No Abstract]   [Full Text] [Related]  

  • 116. [Dendritic cells and immune function in cancer].
    Chaux P
    Pathol Biol (Paris); 1995 Dec; 43(10):897-903. PubMed ID: 8786896
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Suppressive effects of CTLA4-Ig on nasal allergic reactions in presensitized murine model.
    Sato J; Asakura K; Murakami M; Uede T; Kataura A
    Life Sci; 1999; 64(9):785-95. PubMed ID: 10075111
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer.
    Kwon ED; Hurwitz AA; Foster BA; Madias C; Feldhaus AL; Greenberg NM; Burg MB; Allison JP
    Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8099-103. PubMed ID: 9223321
    [TBL] [Abstract][Full Text] [Related]  

  • 119. The role of adhesion and costimulation molecules in graft-versus-host disease.
    Schlegel PG
    Acta Haematol; 1997; 97(1-2):105-17. PubMed ID: 8980616
    [TBL] [Abstract][Full Text] [Related]  

  • 120. CTLA-4, an Essential Immune-Checkpoint for T-Cell Activation.
    Chikuma S
    Curr Top Microbiol Immunol; 2017; 410():99-126. PubMed ID: 28900679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.